Otros idiomas L&C Bio Co., Ltd

Acciones

A290650

KR7290650001

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
19.650 ^KRW	-1,65 %		-4,15 %	-32,24 %

2023	L&C Bio Co., Ltd (KOSDAQ:A290650) anuncia una recompra de acciones por 143.884 acciones.	CI
2023	L&C BIO Co., Ltd autoriza un Plan de Recompra.	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Ray Co., Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.	27/03
Ray Co., Ltd. announced that it expects to receive KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.	25/03
Plasmapp Co., Ltd. announced that it has received KRW 4.999997 billion in funding from DREAMTECH Co., Ltd., L&C Bio Co., Ltd	28/12
Plasmapp Co., Ltd. announced that it expects to receive KRW 4.999997 billion in funding from DREAMTECH Co., Ltd., L&C Bio Co., Ltd	21/12
Tranche Update on L&C Bio Co., Ltd's Equity Buyback Plan announced on November 23, 2023.	08/12
L&C Bio Co., Ltd's Equity Buyback announced on November 23, 2023, has closed with 143,884 shares, representing 0.63% for KRW 4,881 million.	30/11
L&C Bio Co., Ltd announces an Equity Buyback for 143,884 shares.	23/11
L&C BIO Co., Ltd authorizes a Buyback Plan.	23/11
L&C Bio Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Curexo Inc. announced that it has received KRW 40.49999982 billion in funding from L&C Bio Co., Ltd	30/06/22
L&C Bio Co., Ltd announced that it has received KRW 60 billion in funding	29/06/22
L&C Bio Co., Ltd announced that it expects to receive KRW 60 billion in funding	28/06/22
Curexo Inc. announced that it expects to receive KRW 40.49999982 billion in funding from L&C Bio Co., Ltd	23/05/22
NanoFocusRay Co., Ltd. announced that it expects to receive KRW 3.13 billion in funding from L&C Bio Co., Ltd	16/02/22
Netmarble : Skin care kiosk developer lululab secures funding	30/11/20
Lululab Inc. announced that it has received funding from L&C Bio Co., Ltd, Netmarble Corporation, CTK Investment Co., Ltd., Global Medical Research Center and other investors	10/11/20
Tranche Update on L&C BIO Co., LTD's Equity Buyback Plan announced on June 15, 2020.	25/06/20
L&C BIO Co., LTD's Equity Buyback announced on June 15, 2020, has closed with 91,996 shares, representing 1.25% for KRW 9,967.5 million.	24/06/20
L&C BIO Co., LTD announces an Equity Buyback for 91,996 shares.	15/06/20
L&C BIO Co., Ltd authorizes a Buyback Plan.	15/06/20

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas L&C Bio Co., Ltd

Acciones

A290650

KR7290650001

Otros idiomas

Filtros